DV Biomed Co., Ltd. (6539.TWO)
TWD 65.1
(-0.61%)
TWD 65.1
(-0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 332.33 Million | 522.58 Million | 522.58 Million | 463.07 Million | 226.69 Million |
| Net Income | 198.3 Million | 357.31 Million | 395.76 Million | 336.55 Million | 166.28 Million |
| Depreciation & Amortization | 194.02 Million | 183.57 Million | 182.66 Million | 179.41 Million | 172.85 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | 895 Thousand | 2.27 Million |
| Change in working capital | 58.29 Million | 47.06 Million | 3.39 Million | 83.44 Million | -43.24 Million |
| Other non-cash items | -2.21 Million | -94 Thousand | 1.62 Million | -904 Thousand | -71.47 Million |
| Investing Cash Flow | -178.24 Million | -198 Million | -104.76 Million | -290.67 Million | -165.07 Million |
| Investments in PPE | -301.06 Million | -122.21 Million | -69.3 Million | -93.9 Million | -155.08 Million |
| Acquisitions | 35.28 Million | 7.08 Million | - | - | - |
| Investment purchases | -1.32 Billion | -1.28 Billion | -1.2 Billion | -294.65 Million | - |
| Sales/Maturities of investments | 1.4 Billion | 1.2 Billion | 1.17 Billion | 290.11 Million | - |
| Other Investing Activities | 7.56 Million | -1.62 Million | 2.51 Million | -193.51 Million | -9.98 Million |
| Financing Cash Flow | -388.13 Million | -426 Million | -393.86 Million | -232.88 Million | -90.29 Million |
| Debt repayment | -89.3 Million | -77.2 Million | -67.92 Million | -76.36 Million | -87.81 Million |
| Dividends payments | -298.95 Million | -306.65 Million | -325.93 Million | -97.98 Million | -122.48 Million |
| Common Stock Repurchased | - | -42.15 Million | - | -58.53 Million | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 120 Thousand | - | - | - | 120 Million |
| Accounts receivables | 38.29 Million | 53.23 Million | -33.76 Million | 5.1 Million | -1.8 Million |
| Accounts payables | -24.84 Million | - | - | - | - |
| Inventory | 37.38 Million | -1.83 Million | -20.44 Million | 93.71 Million | -59.42 Million |
| Other working capital | 3.04 Million | -167 Thousand | 18.63 Million | 17.47 Million | 17.99 Million |
| Cash at beginning of period | 456.82 Million | 557.61 Million | 533.61 Million | 594.51 Million | 628.88 Million |
| Cash at end of period | 226.99 Million | 456.82 Million | 557.61 Million | 533.61 Million | 594.51 Million |
| Capital Expenditure | -301.06 Million | -122.21 Million | -69.3 Million | -93.9 Million | -155.08 Million |
| Effect of forex changes on cash | 4.21 Million | 644 Thousand | 45 Thousand | -418 Thousand | -5.69 Million |
| Net cash flow / Change in cash | -229.83 Million | -100.79 Million | 24 Million | -60.9 Million | -34.36 Million |
| Free Cash Flow | 31.27 Million | 400.36 Million | 453.28 Million | 369.16 Million | 71.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 12.63 Million | 12.63 Million | 18.81 Million | 198.3 Million | 18.81 Million | 62.63 Million |
| Depreciation & Amortization | 5.51 Million | 5.51 Million | 46.53 Million | 194.02 Million | 46.53 Million | 48.48 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -18.09 Million | -18.09 Million | 43.21 Million | 58.29 Million | 43.21 Million | -3.85 Million |
| Other non-cash items | -693 Thousand | -693 Thousand | -37.9 Million | -2.21 Million | -37.9 Million | -11.75 Million |
| Investing Cash Flow | -14.19 Million | -14.19 Million | -59.09 Million | -178.24 Million | -59.09 Million | -30.02 Million |
| Investments in PPE | -156 Thousand | -156 Thousand | -113.89 Million | -301.06 Million | -113.89 Million | -34.57 Million |
| Acquisitions | - | - | - | 35.28 Million | - | - |
| Investment purchases | - | - | - | -1.32 Billion | - | - |
| Sales/Maturities of investments | - | - | - | 1.4 Billion | - | - |
| Other Investing Activities | -14.04 Million | -14.04 Million | 54.8 Million | 7.56 Million | 54.8 Million | 4.55 Million |
| Financing Cash Flow | 12.19 Million | 12.19 Million | -79.08 Million | -388.13 Million | -79.08 Million | -114.98 Million |
| Debt repayment | - | - | - | -89.3 Million | - | - |
| Dividends payments | -29.89 Million | -29.89 Million | -59.79 Million | -298.95 Million | -59.79 Million | -89.68 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 42.08 Million | 42.08 Million | -19.28 Million | 120 Thousand | -19.28 Million | -25.3 Million |
| Accounts receivables | 92.5 Thousand | 92.5 Thousand | 16.36 Million | 38.29 Million | 16.36 Million | 2.78 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 5 Million | 5 Million | 13.42 Million | 37.38 Million | 13.42 Million | 5.27 Million |
| Other working capital | -23.18 Million | -23.18 Million | 13.43 Million | 3.04 Million | 13.43 Million | -11.9 Million |
| Cash at beginning of period | - | - | - | 456.82 Million | - | - |
| Cash at end of period | -1.73 Million | -1.73 Million | -64.9 Million | 226.99 Million | -64.9 Million | -50.01 Million |
| Capital Expenditure | -156 Thousand | -156 Thousand | -113.89 Million | -301.06 Million | -113.89 Million | -34.57 Million |
| Effect of forex changes on cash | 908 Thousand | 908 Thousand | 2.61 Million | 4.21 Million | 2.61 Million | -505 Thousand |
| Net cash flow / Change in cash | -1.73 Million | -1.73 Million | -64.9 Million | -229.83 Million | -64.9 Million | -50.01 Million |
| Free Cash Flow | -793.5 Thousand | -793.5 Thousand | -43.23 Million | 31.27 Million | -43.23 Million | 60.92 Million |
PPY
OXY
002593
OV8
1418
MEDAF